
Dr. Ursula Anne Matulonis MD
Oncologist | Medical Oncology
44 Binney Street Dana Farber Cancer I Boston MA, 02115About
Ursula A. Matulonis, MD is Medical Director and Program Leader of the Medical Gynecologic Oncology Program at Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School ...
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 2003
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors.
- End of life issues in older patients.
- Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
- Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
- Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
- A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.
- Long-term adjustment of early-stage ovarian cancer survivors.
- Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
- Comparison of the quality of life of early and advanced stage ovarian cancer survivors.
- Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
- Acupuncture as palliative therapy for physical symptoms and quality of life for advanced cancer patients.
- New advances in ovarian cancer.
- Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease.
- Bevacizumab and its use in epithelial ovarian cancer.
- Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels.
Clinical Trials
- Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer
- Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer
- A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Relapsed/ Refractory Endometrioid Endometrial or Endometrioid Ovarian Cancer (P204)
Awards
- Partners Health Care 2000 Partners in Excellence Award
- 2009 Boston Magazine Best Doctors
- 2000 Dennis Thompson Compassionate Care Scholar, Brigham and Women's Hospi
- 2011 Boston Super Doctors
- 1992 American Cancer Society Career Development Award.
- 1994 Lauri Strauss Leukemia Foundation Grant.
- 1995 American Medical Association Leukemia Grant.
- Dana-Farber Cancer Institute Extra Mile Award
Fellowships
- Dana-Farber Cancer Institute, Medical Oncology 1993
- Harvard Medical School, Fellow:Internal Medicine 1990
- Dana Farber Cancer Institute, Fellow:Oncology 1990
Dr. Ursula Anne Matulonis MD's Practice location
Practice At 44 Binney Street Dana Farber Cancer Institute
44 Binney Street Dana Farber Cancer I -Boston, MA 02115Get Direction
Dr. Ursula Anne Matulonis MD's reviews
Write ReviewPatient Experience with Dr. Matulonis
Recommended Articles
- BRCA Gene Risk Status Identified for Ovarian Cancer
It is well-known in the medical community that a specific genetic mutation can increase your risk of getting ovarian cancer and breast cancer. These genes are commonly known as BRCA1 and BRCA 2. While it is more likely that you’ll get ovarian cancer if you happen to have this genetic abnormality,...
- What Are the Signs and Symptoms of Multiple Myeloma?
Multiple myeloma may not show any signs during the early stages called smoldering or asymptomatic multiple myeloma. It is only after a blood or urine test that it can be diagnosed. However, as time goes by, a lot of problems and complications associated with multiple myeloma will start to show....
- How Julia Louis-Dreyfus Battles Breast Cancer Diagnosis
Most people never actually get the chance to meet the celebrities they watch on TV or in the movies. An occasional sighting on the street or maybe a chance encounter often makes for great stories that get told at dinner parties for years to come.Even though many don’t usually have the chance to...
- This Compound in Foods Found to Limit Effectiveness of Ovarian Cancer Drug
Pitavastatin targets HMGCR in ovarian cancer, and it has shown to be capable of regressing Ovcar-4 tumor xenographs. However, recent studies have shown that if a diet includes geranylgeraniol, the effectiveness of pitavastatin may be limited or stopped.Treating ovarian cancerUnfortunately, it is...
- Finding Breast Cancer's Hiding Place: A New Study
Scientists have often wondered why some patients respond so well to chemotherapy and why some don’t. Some cancers are easier to cure while others have a higher risk of relapse and continued issues. Each cancer is different and every cancer treatment is tailored to the cancer cells it’s...
- Holistic Treatments for Bladder Cancer
Bladder cancer happens when there is a tumor that grows within the bladder. Cancer can result from the active division of cells that multiply abnormally and quickly. Bladder cancer begins by affecting a part of the bladder. With time, it can spread and extensively affect the walls of the bladder and...
Nearby Providers
- Dr. Timothy P. Cooley M.D.820 Harrison Avenue Boston Massachusetts 2118
- Nadine M. Tung330 Brookline Avenue Boston Massachusetts 2215
- Dr. Geoffrey I. Shapiro MD PHD450 Brookline Avenue Boston Massachusetts 07715
- Arthur T. Skarin44 Biney Street Boston Massachusetts 02115
- Dr. Susana Maria Campos MD MPH44 Binney St Boston MA 02115
- Dr. Rochelle Gail Scheib MD44 Binney Street Boston MA 02115
Nearest Hospitals
BRIGHAM AND WOMEN'S HOSPITALl
75 FRANCIS STREET BOSTON MA 2115BOSTON CHILDREN'S HOSPITALl
300 LONGWOOD AVENUE BOSTON MA 2115